Featured
Last news
Australian airlines cancel Bali flights after volcano erupts
Several Australian airlines on Wednesday cancelled their flights to and from the Indonesian resort island of Bali, after a nearby volcano catapulted an ash tower miles into the sky.
China snuffs out memorials to victims of deadly car ramming attack
Officials in southern China ramped up security on Wednesday at the site of one of the country's deadliest mass-casualty events in years, snuffing out makeshift memorials to the 35 people killed when a man drove a car into a crowd at a sports complex.
Evacuations, call for aid as Typhoon Usagi approaches Philippines
The Philippines ordered evacuations ahead of Typhoon Usagi on Wednesday, as the UN disaster office sought $32.9 million in aid for the country after storms that killed more than 150 people.
China clears memorial to victims of deadly car ramming attack
Workers in the southern Chinese city of Zhuhai removed flowers and candles early Wednesday from a makeshift memorial to 35 people killed when a man drove a car into a crowd in one of the country's deadliest mass-casualty events in years.
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30, 2024Organizational changes and operating optimization plan implemented to further streamline operations, reduce expenses, and accelerate path to consistent cash flowRyan Selhorn promoted to Chief Financial OfficerCompany to host conference call and webcast today, November 13, 2024, at 4:30 p.m. Eastern time
The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression
Menninger is the only hospital in the U.S. to offer groundbreaking treatment
KindlyMD(R) Announces Third Quarter 2024 Financial Results
Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentiallyKindlyMD now provides more than 90% in-network insurance coverage in Utah
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 3:30 pm GMT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.
Mosaic Announces Quarterly Dividend of $0.21 Per Share
The Mosaic Company (NYSE:MOS) announced today that its Board of Directors declared a quarterly dividend of $0.21 per share on the Company's common stock. The dividend will be paid on December 19, 2024, to stockholders of record at the close of business on December 5, 2024.
374Water Releases Third Quarter 2024 Results and Provides Business Update
New Management Team Advances AirSCWO Technology, Operational in City of Orlando
Tenon Medical Reports Third Quarter 2024 Financial Results
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial -- Dermata continues discussions with potential botulinum toxin partners for DMT410 -- Raised $5.1 million in gross proceeds from financings completed in 3Q 2024 -
Builders, Craftsmen and Innovators Unite: Build Show LIVE Sparks a Movement in Building Science
Build Show LIVE, the brand-new tradeshow held last week in the heart of Austin, was the launch of a transformative movement, bringing together passionate builders, remodelers, architects and manufacturers from 47 states and nine countries, who are committed to elevating the future of residential construction.
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed
Gaucho Holdings Initiates Chapter 11 Reorganization To Protect Core Assets
Strategic Filing Aims to Protect Operational Continuity for the Benefit of Stockholders
Pure Cycle Announces Financial Results For the Year Ended August 31, 2024
Pure Cycle Corporation (NASDAQ Capital Market:PCYO) announced its financial results for the year ended August 31, 2024. Pure Cycle reported $11.6 million of net income for the year ended August 31, 2024, which is a 147% increase compared to 2023, and marks our seventh consecutive year and twenty-first consecutive fiscal quarter with positive net income. Pure Cycle reported $0.48 of earnings per fully diluted common shares, which is up from $0.19 in 2023, a 153% increase. We recognized a 135% increase in lot sales revenue for the year ended August 31, 2024 compared to 2023, due to an increase in our development activity. Pure Cycle continues to develop its Sky Ranch Master Planned Community, and as of August 31, 2024, we are actively working on Phases 2A, 2B and 2C. Phase 2A and 2B are substantially completed with finished lots delivered to homebuilders. We expect home builders to be able to begin construction in Phase 2C during fiscal 2025 and to start home building in Phase 2D in fiscal 2026.
Dalet and Caretta Research Publish "Future of Newsroom Workflows" Report
Insights Reveal the Need for News Organizations to Transform Operations to Thrive in a Rapidly Changing Landscape
ANGLE presents two posters at EACR
PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation of CTCs
Jaguar Health Reports Third Quarter 2024 Financial Results
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 million and 11% versus net Q3 2023 revenue of $2.8 millionJaguar reported significant results in breast cancer patients in its phase 3 OnTarget trial for its cancer supportive care drug crofelemer; results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS)Jaguar initiated commercial launch in October 2024 for Gelclair®, the company's third prescription product, in alignment with Jaguar's focus on cancer supportive careJaguar is initiating two Phase 2 trials in Q4, 2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel syndrome (SBS) with intestinal failure in the US, EU, and Middle East/North Africa (MENA) regions; results of IITs expected by the end of 2024 and throughout 2025REMINDER: Jaguar to host investor webcast Wednesday, November 13th at 8:30 a.m. Eastern regarding Q3 2024 financials and company updates; Click here to register for webcast
Noble Roman's Announces Third Quarter 2024 Financial Data
Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub ("CPP"), today announced financial data for the third quarter 2024 and other company highlights.
Noble Roman's to Release 3rd Quarter 2024 Financial Data on November 13th; to Host Conference Call on November 14th at 4:00 PM EST
Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced that it will report 2024 3rd quarter financial data on Wednesday, November 13th after the markets close. Noble Roman's also announced that it will host a conference call on Thursday, November 14th from 4:00 to 4:45 PM EST. Those interested in participating in the conference call should dial in at 317-300-7896 and use the participation code 499795 (no pin number required - callers will press 5* to ask questions when Q&A time is announced).
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024.
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector.
Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
Taiwan regulatory approval for the trial expected in Q1 2025
The WiTT Group, Inc Completes a Financing Round Led by Sopris Capital With Participation From LEAD to Accelerate Growth and Build Out Its Patient Engagement and Data Platform
The WiTT Group™, Inc. a Digital Health and FinTech company focused on solving the non-clinical challenges patients face as they go through treatment, has announced the completion of a financing round led by Sopris Capital with participation from LEAD.
New Study Shows 800%+ Spike in Searches to Move Abroad Post-Election - moveBuddha Reveals Where They Want to Go
Following the election, significant spikes in searches for moving out of America suggest heightened interest in international relocation. moveBuddha identifies the states with the highest interest in top international destinations and each state's top move-to country.
Venezuela crackdown helped avert 'civil war': attorney general
Venezuela's Attorney General Tarek William Saab defended the state's crackdown on opposition supporters after disputed July elections, telling AFP the authorities' actions helped avert a "civil war."
Fifteen inmates killed in new Ecuador jail massacre
At least 15 inmates were killed and 14 injured in clashes Tuesday at a prison in the Ecuadoran port of Guayaquil, the latest in a series of massacres blamed on a war between drug cartels.
35 killed, dozens wounded in south China car ramming
A man killed 35 people and injured 43 more when he ploughed his car into those exercising around a sports centre in the southern Chinese city of Zhuhai on Monday, local police said Tuesday.
Boeing expects post-strike output recovery to take several weeks
Boeing said Tuesday that it delivered 14 aircraft in October, but production will likely take several weeks to return to normal after a worker strike that hit operations at two major assembly plants.
Lindt disputes US lawsuit claims, stands by 'excellence' labelling
Top Swiss chocolatier Lindt & Sprungli is disputing claims brought by US consumers in a class action lawsuit concerning the levels of heavy metals found in its chocolate bars.
Russia jails doctor over alleged Ukraine comments during consultation
Russia on Tuesday sentenced a 68-year-old paediatrician to five and a half years in prison for allegedly criticising the Ukraine campaign during an appointment, after she was denounced by the ex-wife of a soldier killed in combat.